Argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
TD Cowen Maintains Argenx SE(ARGX.US) With Buy Rating
TD Cowen Remains a Buy on Argenx Se (ARGX)
US stocks gold rush | Performance and stock prices soar! Netflix, robotic surgery leader ISRG hit record highs; Gold price breaks through $2700! Kinross Gold and other multiple golden industrial concepts collectively celebrate.
Bitcoin approaches $70,000! Bitcoin whale MSTR soared 11% last Friday, making up for the previous 4 days of decline, with the stock price back above the $200 mark.
Wedbush Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $560
UBS Keeps Their Hold Rating on Argenx Se (ARGX)
European Equities Traded in the US as American Depositary Receipts Move Slightly Higher in Thursday Trading
Citi Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $635
Express News | Argenx SE : Citigroup Raises Target Price to $635 From $512
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Argenx Says New Data on Its Generalized Myasthenia Gravis Treatments Demonstrate 'Sustained Responses'
Argenx SE Shows Promising Immunology Program Results
Argenx Highlights Patient Impact Data Across Immunology Programs At 2024 AANEM And MGFA Scientific Session
Raymond James Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $605
Raymond James Reinstates Strong Buy on Argenx, Announces $605 Price Target
Wells Fargo Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $547
Argenx SE (ARGNF) Q2 2024 Earnings Call Highlights: Strong Financial Performance Amid ...
Piper Sandler Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $553
Limited upside potential for the stock price, halozyme therapeutics (HALO.US) downgraded by wells fargo & co.
Wells Fargo & Co downgraded the rating of USA biotechnology company Halozyme Therapeutics (HALO.US) from "shareholding" to "in line with large cap", with a target price of $62.
Zacks.com Featured Highlights Include Argenx SE Alphatec and Olin